QTTB übertreffen die 15 der letzten 31Schätzungen.
48%
Nächster Bericht
Datum des nächsten Berichts
06. Mai 2026
Estimate forQ1 26(Revenue/ EPS)
--
/
-$0.90
Implizierte Änderung vonQ3 25(Revenue/ EPS)
--
/
+50.00%
Implizierte Änderung vonQ1 25(Revenue/ EPS)
--
/
--
Q32 Bio Inc. Common Stock earnings per share and revenue
On 13. Nov. 2025, QTTB reported earnings of -0.60 USD per share (EPS) for Q3 25, beating the estimate of -1.21 USD, resulting in a 50.53% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -9.05% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.90 USD, with revenue projected to reach -- USD, implying an increase of 50.00% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Q32 Bio Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Q32 Bio Inc. Common Stock reported EPS of -$0.60, beating estimates by 50.53%, and revenue of $0.00, 0% as expectations.
How did the market react to Q32 Bio Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -9.05%, changed from $2.43 before the earnings release to $2.21 the day after.
When is Q32 Bio Inc. Common Stock expected to report next?
The next earning report is scheduled for 06. Mai 2026.
What are the forecasts for Q32 Bio Inc. Common Stock's next earnings report?
Based on 3
analysts, Q32 Bio Inc. Common Stock is expected to report EPS of -$0.90 and revenue of -- for Q1 2026.